Abcam, a global innovator in life sciences reagents and tools, has announced the successful completion of its acquisition of BioVision and the expansion of its immunoassay capacity in Eugene, OR. According to a statement, “The addition of BioVision enhances Abcam’s in-house innovation and adds scale to support the biochemical assay and cellular assay markets. The…